Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  26 results for ""GLUCAGON-like peptide-1 receptor""

Your Filters

Publication : acta diabetologica Subject : autonomic nervous system diseases Subject : biomarkers Subject : diabetes mellitus, type 2 Subject : glucose intolerance Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Usefulness of circulating EPAC1 as biomarkers of therapeutic response to GLP-1 receptor agonists.

Subjects: GLUCAGON-like peptide-1 agonists; GLUCAGON-like peptide-1 receptor; TYPE 2 diabetes

  • Source: Acta Diabetologica; Nov2022, Vol. 59 Issue 11, p1437-1442, 6p

Record details

Read More Add to Saved list
×
Academic Journal

Blood pressure-lowering effects of SGLT2 inhibitors and GLP-1 receptor agonists for preventing of cardiovascular events and death in type 2 diabetes: a systematic review and meta-analysis.

  • Authors : Diallo A; University Montpellier, 80 Avenue Augustin Fliche, 34295, Montpellier Cedex 5, France. .; Carlos-Bolumbu M

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/chemically induced

  • Source: Acta diabetologica [Acta Diabetol] 2023 Dec; Vol. 60 (12), pp. 1651-1662. Date of Electronic Publication: 2023 Jul 13.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy.

  • Authors : Oezer K; 5th Medical Department, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. .; Kolibabka M

Subjects: Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/drug therapy ; Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/etiology ; Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/metabolism

  • Source: Acta diabetologica [Acta Diabetol] 2023 Nov; Vol. 60 (11), pp. 1551-1565. Date of Electronic Publication: 2023 Jul 09.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

GLP-1RAs and cardiovascular disease: is the endothelium a relevant platform?

  • Authors : Menghini R; Departments of Systems Medicine, University of Rome 'Tor Vergata', Rome, Italy. .; Casagrande V

Subjects: Diabetes Mellitus, Type 2* ; Cardiovascular Diseases*; Humans

  • Source: Acta diabetologica [Acta Diabetol] 2023 Nov; Vol. 60 (11), pp. 1441-1448. Date of Electronic Publication: 2023 Jul 04.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus.

  • Authors : Berra C; Department of Endocrinology, Nutrition and Metabolic Diseases, IRCCS Multimedica, Milan, Italy. .; Manfrini R

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/chemically induced

  • Source: Acta diabetologica [Acta Diabetol] 2023 Sep; Vol. 60 (9), pp. 1257-1266. Date of Electronic Publication: 2023 Jun 04.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Glucagon-like peptide-1 analog therapy in rare genetic diseases: monogenic obesity, monogenic diabetes, and spinal muscular atrophy.

  • Authors : Zaitoon H; Pediatric Endocrinology and Diabetes Unit, Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, 6 Weizmann St, 64239-06, Tel Aviv, Israel.; Lubetzky R

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Metformin*/Metformin*/Metformin*/therapeutic use ; Muscular Atrophy, Spinal*/Muscular Atrophy, Spinal*/Muscular Atrophy, Spinal*/drug therapy

  • Source: Acta diabetologica [Acta Diabetol] 2023 Aug; Vol. 60 (8), pp. 1099-1108. Date of Electronic Publication: 2023 May 09.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes.

  • Authors : Falcetta P; Department of Clinical and Experimental Medicine, University of Pisa, 56124, Pisa, Italy.; Nicolì F

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Male ; Humans

  • Source: Acta diabetologica [Acta Diabetol] 2023 Jan; Vol. 60 (1), pp. 53-60. Date of Electronic Publication: 2022 Sep 27.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus.

  • Authors : Burlina S; Department of Medicine - DIMED, University of Padua, Padua, Italy.; Dalfrà MG

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Female

  • Source: Acta diabetologica [Acta Diabetol] 2023 Jan; Vol. 60 (1), pp. 137-138. Date of Electronic Publication: 2022 Sep 22.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer database.

  • Authors : Rathmann W; Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Auf'm Hennekamp 65, 40225, Düsseldorf, Germany. .; Kostev K

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology

  • Source: Acta diabetologica [Acta Diabetol] 2022 Nov; Vol. 59 (11), pp. 1443-1451. Date of Electronic Publication: 2022 Aug 06.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials of new antidiabetic drugs: a meta-analysis of digitalized individual patient data.

  • Authors : Kuss O; Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. .; Centre for Health and Society, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. .

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/etiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Dipeptidyl-Peptidase IV Inhibitors*/Dipeptidyl-Peptidase IV Inhibitors*/Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use

  • Source: Acta diabetologica [Acta Diabetol] 2022 Oct; Vol. 59 (10), pp. 1349-1359. Date of Electronic Publication: 2022 Jul 25.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  26 results for ""GLUCAGON-like peptide-1 receptor""